Overview

Thiamine as a Metabolic Resuscitator After Cardiac Arrest

Status:
Recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo controlled study to investigate the effect of intravenous thiamine (vitamin B1) on lactate, cellular oxygen consumption, global oxygen consumption and biomarkers of neurologic injury after out-of-hospital cardiac arrest (OHCA). .
Phase:
Phase 2
Details
Lead Sponsor:
Michael Donnino
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Thiamine
Vitamins